Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.

Slides:



Advertisements
Similar presentations
Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
Advertisements

Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Mark Horton MD MSPH April 28, 2011 The Economy, Health Care Reform and TB Control in California.
Local Health Department Perspective Electronic Medical Record Software and Health Information Exchanges Kathleen Cook Information & Fiscal Manager, Lincoln-Lancaster.
TM PEN: CDC Guidance for Developing Plans and Reports 2011 TB ETN/PEN Conference Awal Khan, PhD Lead, Program Evaluation Team Field Services and Evaluation.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
West Virginia’s Tuberculosis Control Program Hx and Epi MissionTransmissionRequirements Channels of Communication.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
New Tuberculosis Reports Melissa Ehman Epidemiologist California TB Controllers Association Meeting October 22, 2010.
National TB/ Leprosy Programme Manager
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
Evaluation Methods.
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
1 TB/HIV Project in the Philippines Yumiko Yanase.
Assessment of Program Evaluation Activities in Tuberculosis Control Programs — United States, 2009–2010 Silvia M. Trigoso, MPH Fellow, Public Health Prevention.
Tuberculosis Surveillance and Disease Intersections in California
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
Community Feedback and Involvement in [Health Department’s] Proposed Data to Care Program [Name of Provider Session Date of Provider Session]
Improving TB-DM Care in the Pacific: Partnerships and Progress R. Brostrom, MD-MSPH Hawaii TB Control Branch Chief Regional TB Field Medical Officer, CDC-DTBE.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
1 Epidemiology of Pediatric Tuberculosis in the United States, 1993–2006 Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis.
Evaluating Tuberculosis Surveillance and Action in an Urban and Rural Setting Kristine Lykens, Ph.D. In collaboration with Anita Kurian, MPH, MBBS Patrick.
Tuberculosis Indicators Project (TIP) Overview Tuberculosis Control Branch (TBCB ) Division of Communicable Disease Control Center for Infectious Diseases.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
The Cohort Review Process The Cohort Review Process Kim Field RN, MSN WA State DOH Tuberculosis Program.
Determination of HIV Infection Among TB Patients in California, 2008 Darryl Kong 1, Jennifer Flood 1, Suzanne Marks 2, James Watt 1 1 California Department.
Unit 10. Monitoring and evaluation
Local Challenges Implementing State Policy: Evaluating the Interim Guidance for Monitoring and Movement of Persons with Potential Ebola Exposure in Southeast.
Division of HIV/AIDS Prevention CDC-RFA-PS
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
Elements of the Cohort Review Approach Harvey L. Marx, Jr. Lisa Schutzenhofer TB Program Controller TB Program Manager.
1 How Complete is California’s HIV Status Determination Among 2008 TB Cases? Darryl Kong, MPH TB Control Branch California Department of Public Health.
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Involvement of community-based organizations in the fight against Tuberculosis and TB/VIH co-infection in Burkina Faso Dr Fodé SIMAGA
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
HIV/STD Partner Services Recommendations Cindy Getty & Rheta Barnes Divisions of HIV/AIDS Prevention & STD Prevention National Centers for HIV/AIDS, Viral.
California Update : TB Epidemiology and Indicators CTCA October 22, 2010 Jennifer Flood MD MPH Chief, Surveillance and Epidemiology Tuberculosis Control.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
2010 TB Case Surveillance California TB Controllers Association October 22, 2010 Saul Kanowitz, M.P.H. Surveillance Analyst Tuberculosis Control Branch.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
GALVESTON COUNTY TB PROGRAM  SYED HAIDRY TB PROGRAM MANAGER  Dr. MARK GUIDRY CEO, HEALTH AUTHORITY & TB CLINICIAN.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
T T H H I I Tennessee Health Indicators PROGRAM DIRECTOR: DR. JON WARKENTIN DATA DIRECTOR/EPIDEMIOLOGIST: JASON CUMMINS, MPH Tuberculosis Elimination Program.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
TB Genotyping and Whole Genome Sequencing in California
This is an archived document.
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Mark Lobato, MD Division of TB Elimination
Surveillance for TB in HIV Care and Treatment Settings (CTS)
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Using Whole Genome Sequencing Analysis in California
South Africa: From ProTest to Nationwide Implementation
Building Public Health Nursing Capacity through Shared Services
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
Perspectives from Los Angeles County Tuberculosis Control Program
Presentation transcript:

Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center for Infectious Diseases California Department of Public Health October 15, 2008

Objectives Review California TB indicators Consider indicators relevant to HIV/TB Discuss possible next steps in developing cross-cutting indicators

TB Indicators Project (TIP) Partnership between TBCB and TB programs of the 16 local health departments (LHDs) with the highest TB morbidity Formal process for using indicators to evaluate and improve program performance Implemented beginning in 2000 STATE TIP TEAM Program Liaison Epidemiologist Fiscal Analyst LOCAL TIP TEAM TB Controller Program Manager Epidemiologist Staff

How Did We Create Indicators? Defined goal areas Reviewed standards Identified available data sources Developed indicators Assessed indicators according to set criteria: –Ethical –Useful –Representative –Understandable –Data Accessible –Robust (Valid) –Reliable Set objectives

TIP Indicators Identification and Reporting TB Case Rate Timely Reporting Complete Reporting Culture Identification Completion of Therapy Recommended Initial Therapy Timely Treatment Culture Conversion Appropriate DOT Inappropriate SAT Timely Completion of Therapy Not Defaulting from Treatment Contact Investigation Contact Identification Contact Evaluation Contact LTBI Treatment Initiation Contact LTBI Treatment Completion Sentinel Events Pediatric TB Cases TB Deaths Infrastructure Program Capacity (self- assessment)

Culture Conversion TIP Indicator Report sss

Culture Conversion TIP Indicator Methods

Culture Conversion TIP Indicator Goal, Indicator, Objective Goal C: Ensure timely completion of appropriate therapy for all persons with tuberculosis Indicator C3: Proportion of sputum culture- positive TB cases with documented conversion to sputum culture-negative within 90 days of initiation of treatment Objective: At least 70% of sputum culture- positive TB cases will have documented conversion to sputum culture-negative within 90 days of initiation of treatment, for cases counted in 2006

TIP Process 1.Complete Infrastructure Self-Assessment 2.Review indicator data 3.Analyze and plan Verify problem Determine reasons for problem 4.Develop interventions 5.Implement interventions 6.Evaluate and reassess

TIP Benefits and Challenges Improvements in many key areas Program performance Staff capacity and communication Data quality TB patient care processes Challenges –Limitations with using TIP indicator data –Competing priorities for LHD and TBCB staff

Outcomes Summary Indicator # of LHDs Targeting Indicator Average Performance Change Contacts Completing TB Therapy1- 3% Recommended Initial Therapy10% Timely Reporting2+ 9% Complete Reporting1+ 12% Timely Completion of Therapy3+ 13% Pediatric TB3+ 14% Contact Evaluation3+ 16% Culture Conversion3+ 23% Inappropriate SAT1+ 68% Appropriate DOT3+ 128%

LHD Assessment of TIP Methods In 10 jurisdictions where long-term TIP outcome data are available, structured interviews were conducted by TBCB staff with LHD key informants. Results On a scale of 1 (low) to 5 (high), TIP participants reported: Average satisfaction with results : 4.2 Average contribution of TIP to results: 3.4

Web-Based Indicator Reports Secure system access ( –Access to California-wide TIP reports for all users –For TIP participants, access to individual county reports System always available Tailored reports –By year –By indicator Data updated several times per year

CDC’s Proposed TB Indicators A set of indicators will be included in the TB Cooperative Agreements for new funding period Several prioritized indicators will be visualized in a web-based system modeled on the TIP online reports, starting 2009 One new TB indicator intersects with HIV:  Increase the proportion of TB cases with positive or negative HIV test result reported to 88.7% by 2015

Possible HIV/TB Indicators for Discussion HIV Testing of Persons with TB TB cases alive at diagnosis with positive or negative HIV test result reported TB Testing of Persons with HIV HIV cases alive at diagnosis with positive or negative TB test result reported

Rationale for Testing from white paper by the National TB Controllers Association HIV testing of TB patients, suspects and contacts: –Detect new HIV infections –Improved outcomes for TB patients with HIV –Make referrals to HIV care and support services –Initiate and coordinate TB and HIV treatment –Prioritize contacts for TB investigation –Educate patients about TB/HIV TB testing of known HIV-infected patients, and treatment of TB and LTBI: –Prevent transmission among a highly vulnerable population and prevent future TB disease –Educate patients about risks and consequences of TB

Next Steps Do we agree on the need for indicators? Discuss possible indicators What are the next steps to being able to measure them?

Want More Information? General questions about TIP and TIP implementation Anne Cass, MPH TIP Coordinator (619) On-line TIP reports, national TB indicators, objective setting Melissa Ehman, MPH Lead TIP Epidemiologist (510)

Acknowledgements Local health department staff participating in TIP TB Control TIP staff: David Beers, Anne Cass, Bryan Faulstich, Jennifer Flood, Michael Joseph, Lisa Pascopella, Gayle Schack, Stephanie Spencer, Joan Sprinson, Lisa True, Jan Young Division of TB Elimination Evaluation Workgroup, CDC